| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
ELDN
Eledon Pharmaceuticals
|
Aug 14, 2026 | BUY |
Strong Buy
+350.3% avg upside
11 analysts
|
$10.00
189.81% Upside
|
-2.5% | · |
|
UNCY
Unicycive Therapeutics
|
Aug 13, 2026 | BUY |
Strong Buy
+824.9% avg upside
10 analysts
|
$50.00
788.03% Upside
|
+0.9% | · |
|
NTRB
Nutriband
|
Aug 12, 2026 | BUY |
Strong Buy
+221.5% avg upside
1 analyst
|
$15.00
221.50% Upside
|
+51.7% | · |
|
NRSN
Neurosense Therapeutics Ltd.
|
Aug 11, 2026 | BUY |
Strong Buy
+2125.6% avg upside
5 analysts
|
$9.00
2291.73% Upside
|
-20.7% | · |
|
NNVC
NanoViricides
|
Aug 11, 2026 | BUY |
Strong Buy
+332.3% avg upside
3 analysts
|
$6.00
351.12% Upside
|
-2.2% | · |
|
GYRE
Gyre Therapeutics
|
Aug 10, 2026 | BUY |
Strong Buy
+200.5% avg upside
15 analysts
|
$20.00
189.46% Upside
|
+2.8% | · |
|
OCGN
Ocugen
|
Aug 07, 2026 | BUY |
Strong Buy
+568.0% avg upside
17 analysts
|
$12.00
763.38% Upside
|
+8.6% | · |
|
GOVX
GeoVax Labs
|
Jul 29, 2026 | BUY |
Strong Buy
+11904.3% avg upside
5 analysts
|
$10.00
1448.96% Upside
|
-7.4% | · |
|
CVKD
Cadrenal Therapeutics, Inc.
|
Jul 14, 2026 | BUY |
Strong Buy
+1701.3% avg upside
2 analysts
|
$45.00
2695.05% Upside
|
-33.5% | · |
|
MAIA
MAIA Biotechnology, Inc.
|
Jul 09, 2026 | BUY |
Strong Buy
+763.3% avg upside
2 analysts
|
$14.00
907.11% Upside
|
-4.8% | · |
|
GLSI
Greenwich LifeSciences
|
Jun 02, 2026 | BUY |
Strong Buy
+241.8% avg upside
2 analysts
|
$45.00
169.85% Upside
|
-31.4% | · |
|
COCP
Cocrystal Pharma
|
May 27, 2026 | BUY |
Strong Buy
+595.7% avg upside
2 analysts
|
$10.00
769.63% Upside
|
-0.9% | · |
|
CRDF
Cardiff Oncology
|
May 22, 2026 | BUY |
Buy
+1045.0% avg upside
18 analysts
|
$12.00
1263.52% Upside
|
-49.4% | · |
|
STLN
Starling Oncology Institute
|
May 08, 2026 | BUY |
Strong Buy
+9.3% avg upside
7 analysts
|
$8.00
23.80% Upside
|
+66.5% | · |
|
TNXP
Tonix Pharma
|
Mar 16, 2026 | BUY |
Strong Buy
+122.8% avg upside
8 analysts
|
$37.00
194.84% Upside
|
-7.4% | · |
|
ZOMDF
Zomedica
|
Jun 27, 2025 | HOLD |
Buy
+1297.0% avg upside
3 analysts
|
— | +140.0% | · |
|
TRAW
Traws Pharma
|
Feb 24, 2025 | HOLD |
Buy
+5843.4% avg upside
10 analysts
|
— | -61.8% | · |
|
PDSB
PDS Biotechnology
|
Feb 24, 2025 | HOLD |
Strong Buy
+6340.0% avg upside
11 analysts
|
— | -48.1% | · |
|
ZVSA
ZyVersa Therapeutics
|
Jan 21, 2025 | HOLD |
Buy
+116122.8% avg upside
2 analysts
|
— | -88.2% | · |
|
GNPX
Genprex
|
Aug 16, 2022 | BUY |
Strong Buy
+89.8% avg upside
5 analysts
|
$5.00
26.60% Upside
|
· | · |
|
LCTX
Lineage Therap
|
Aug 15, 2022 | BUY |
Strong Buy
+412.9% avg upside
16 analysts
|
$9.00
733.43% Upside
|
-8.2% | · |
|
AU:IMU
Imugene
|
Jun 01, 2022 | BUY |
Strong Buy
+700.0% avg upside
2 analysts
|
$0.70
758.01% Upside
|
· | · |
|
AVXL
Anavex Life Sciences
|
May 14, 2021 | BUY |
Strong Buy
+643.3% avg upside
9 analysts
|
$19.50
501.93% Upside
|
-22.5% | · |
|
YTENQ
Yield10 Bioscience
|
Feb 09, 2021 | BUY |
Hold
+37874900.0% avg upside
6 analysts
|
$27.00
26999900.08% Upside
|
· | · |
|
ORMP
Oramed Pharm
|
Jan 26, 2021 | BUY |
Strong Buy
+299.2% avg upside
7 analysts
|
$15.00
211.91% Upside
|
+25.4% | · |
|
CNSY
Cerenome
|
Jan 25, 2021 | BUY |
Strong Buy
+946.4% avg upside
11 analysts
|
$8.00
160.49% Upside
|
· | · |
|
CBUS
Cibus
|
Jan 24, 2021 | BUY |
Buy
+910.6% avg upside
10 analysts
|
$14.00
723.57% Upside
|
· | · |
|
CNSP
CNS Pharmaceuticals
|
Dec 28, 2020 | HOLD |
Strong Buy
+380.2% avg upside
5 analysts
|
— | · | · |
|
OTLK
Outlook Therapeutics
|
Dec 24, 2020 | BUY |
Buy
+1330.3% avg upside
11 analysts
|
$6.00
827.07% Upside
|
· | · |
|
ONCSQ
OncoSec Medical
|
Nov 12, 2020 | BUY |
Strong Buy
+4699999900.0% avg upside
9 analysts
|
$8.00
799999899.94% Upside
|
· | · |
|
BNTC
Benitec Biopharma
|
Oct 05, 2020 | HOLD |
Strong Buy
+85.5% avg upside
14 analysts
|
— | +9.1% | · |
|
JAGX
Jaguar Animal Health
|
May 28, 2020 | BUY |
Strong Buy
+440.3% avg upside
5 analysts
|
$5.00
476.28% Upside
|
· | · |
|
MTVA
MetaVia
|
Feb 18, 2020 | BUY |
Strong Buy
+1948.6% avg upside
13 analysts
|
$30.00
1954.87% Upside
|
· | · |
|
SCYX
SCYNEXIS
|
Nov 01, 2018 | HOLD |
Strong Buy
+151.6% avg upside
10 analysts
|
— | · | · |
|
INDP
Indaptus Therapeutics
|
Nov 01, 2018 | HOLD |
Buy
+7089.9% avg upside
6 analysts
|
— | · | · |
|
VTVT
vTv Therapeutics
|
Apr 10, 2018 | HOLD |
Strong Buy
+8.0% avg upside
13 analysts
|
$1.00
97.07% Downside
|
+110.1% | · |
|
LSTA
Lisata Therapeutics
|
Feb 02, 2018 | HOLD |
Buy
+735.5% avg upside
11 analysts
|
— | · | · |
|
HURA
TuHURA Biosciences
|
Feb 02, 2018 | HOLD |
Strong Buy
+356.2% avg upside
8 analysts
|
— | · | · |
|
AIXC
AIxCrypto Holdings
|
Feb 02, 2018 | HOLD |
Strong Buy
+882.1% avg upside
7 analysts
|
— | · | · |
|
MTNB
Matinas BioPharma
|
Feb 02, 2018 | HOLD |
Buy
+7106.5% avg upside
7 analysts
|
— | · | · |
|
CRBP
Corbus Pharmaceuticals
|
Feb 02, 2018 | HOLD |
Strong Buy
+238.2% avg upside
20 analysts
|
— | · | · |
|
ROSGQ
Rosetta Genomics
|
Feb 02, 2018 | HOLD |
Hold
+4499900.0% avg upside
4 analysts
|
— | · | · |
|
ACAD
ACADIA Pharmaceuticals
|
Aug 05, 2016 | HOLD |
Strong Buy
+25.1% avg upside
43 analysts
|
$41.00
38.98% Upside
|
-15.9% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.